Sorafenib-induced acute myocardial infarction due to coronary artery spasm

Journal of Cardiology

Volumn 54, Issue 3, 2009, Pages 512-515

  Arima, Yuichiro ^a   Oshima, Shuichi ^a   Noda, Katsuo ^a   Fukushima, Hironobu ^a   Taniguchi, Izumi ^a   Nakamura, Shinichi ^a   Shono, Makoto ^a   Ogawa, Hisao ^b  

^a Kumamoto Central Hospital   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Coronary artery spasm; Myocardial infarction; Sorafenib

Indexed keywords

CREATINE KINASE; ERGOMETRINE; FLUINDOSTATIN; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NICORANDIL; NIFEDIPINE; NITRATE; SORAFENIB; TROPONIN I; VALSARTAN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADVANCED CANCER; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CONTROLLED STUDY; CORONARY ARTERY SPASM; CORONARY RISK; CREATINE KINASE BLOOD LEVEL; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; LEUKOCYTE COUNT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROVOCATION TEST; RELAPSE; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; THORAX PAIN; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARCINOMA, RENAL CELL; CORONARY VASOSPASM; HUMANS; KIDNEY NEOPLASMS; MALE; MYOCARDIAL INFARCTION; PROTEIN KINASE INHIBITORS; PYRIDINES; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 70450224682     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.03.009     Document Type: Article

References (14)

1. Wilhelm S.M., Adnane L., Newell P., Villanueva A., Llovet J.M., and Lynch M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther 7 (2008) 3129-3140
2. Escudier B., Eisen T., Stadler W.M., Szczylik C., Oudard S., Siebels M., Negrier S., Chevreau C., Solska E., Desai A.A., Rolland F., Demkow T., Hutson T.E., Gore M., Freeman S., et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356 (2007) 125-134
3. Llovet J.M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J.F., de Oliveira A.C., Santoro A., Raoul J.L., Forner A., Schwartz M., Porta C., Zeuzem S., Bolondi L., Greten T.F., et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359 (2008) 378-390
4. Yasue H., Nakagawa H., Itoh T., Harada E., and Mizuno Y. Coronary artery spasm-clinical features, diagnosis, pathogenesis, and treatment. J Cardiol 51 (2008) 2-17
5. Okumura K., Yasue H., Matsuyama K., Ogawa H., Morikami Y., Obata K., and Sakaino N. Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery. J Am Coll Cardiol 19 (1992) 752-758
6. Wakabayashi K., Suzuki H., Honda Y., Wakatsuki D., Kawachi K., Ota K., Koba S., Shimizu N., Asano F., Sato T., and Takeyama Y. Provoked coronary spasm predicts adverse outcome in patients with acute myocardial infarction: a novel predictor of prognosis after acute myocardial infarction. J Am Coll Cardiol 52 (2008) 518-522
7. Tun A., and Khan I.A. Myocardial infarction with normal coronary arteries: the pathologic and clinical perspectives. Angiology 52 (2001) 299-304
8. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83 (2003) 1325-1358
9. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T., Tamakawa H., Yamagami K., Inui J., Maekawa M., and Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389 (1997) 990-994
10. Nakao F., Kobayashi S., Mogami K., Mizukami Y., Shirao S., Miwa S., Todoroki-Ikeda N., Ito M., and Matsuzaki M. Involvement of Src family protein tyrosine kinases in Ca(2+) sensitization of coronary artery contraction mediated by a sphingosylphosphorylcholine-Rho-kinase pathway. Circ Res 91 (2002) 953-960
11. Kandabashi T., Shimokawa H., Miyata K., Kunihiro I., Eto Y., Morishige K., Matsumoto Y., Obara K., Nakayama K., Takahashi S., and Takeshita A. Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm. Arterioscler Thromb Vasc Biol 23 (2003) 2209-2214
12. Pawlak G., and Helfaman D.M. MEK mediates v-Src-induced disruption of the actin cytoskeleton via inactivation of the Rho-ROCK-LIM kinase pathway. J Biol Chem 277 (2002) 26927-26933
13. Lee S., and Helfman D.M. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. J Biol Chem 279 (2004) 1885-1891
14. Yeh E.T.H., Tong A.T., Lenihan D.J., Yusuf S.W., Swafford J., Champion C., Durand J.B., Gibbs H., Zafarmand A.A., and Ewer M.S. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109 (2004) 3122-3131